BioGend Therapeutics Co (ROCO:6733) YoY Rev. per Sh. Growth : 31.85% (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is BioGend Therapeutics Co YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. BioGend Therapeutics Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 was 31.85%.

BioGend Therapeutics Co's Revenue per Share for the three months ended in Mar. 2025 was NT$0.39.

BioGend Therapeutics Co YoY Rev. per Sh. Growth Historical Data

The historical data trend for BioGend Therapeutics Co's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGend Therapeutics Co YoY Rev. per Sh. Growth Chart

BioGend Therapeutics Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-11.11

475.00

231.52

199.67

49.02

BioGend Therapeutics Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															201.03	-10.21	97.21	28.04	31.85

BioGend Therapeutics Co YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

BioGend Therapeutics Co's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2024 )
=	(Revenue per Share (A: Dec. 2024 )	-	Revenue per Share (A: Dec. 2023 ))	/	\| Revenue per Share (A: Dec. 2023 ) \|
=	(1.362	-	0.914)	/	\| 0.914 \|
=	49.02 %

BioGend Therapeutics Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY Rev. per Sh. Growth (Q: Mar. 2025 )
=	(Revenue per Share (Q: Mar. 2025 )	-	Revenue per Share (Q: Mar. 2024 ))	/	\| Revenue per Share (Q: Mar. 2024 )) \|
=	(0.385	-	0.292)	/	\| 0.292 \|
=	31.85 %

BioGend Therapeutics Co YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of BioGend Therapeutics Co's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGend Therapeutics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yuanqu Street, 4th Floor, Number 3-2, Nangang District, Taipei, TWN, 115

Website

https://www.biogend.com.tw

BioGend Therapeutics Co Ltd is a Taiwan-based company involved in the research and development of orthopedic medical equipment and related products and the sale of related products. It is involved in the research and development of inventive cartilage repair technology and products, adipose stem cell extraction technology, and others. Geographically, the company generates a majority of its revenue from Taiwan, followed by China and other regions.

BioGend Therapeutics Co Headlines

No Headlines